Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Context Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $64.17M | $64.17M - $64.17M | $0.00 | -$0.36 | 6 |
| Dec 2029 | $10.58M | $10.58M - $10.58M | $0.00 | -$0.518 | 3 |
| Dec 2028 | $2.45M | $2.45M - $2.45M | $0.00 | -$0.527 | 7 |
| Dec 2027 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.408 | 0 |
| Dec 2026 | $2.00M | $2.00M - $2.00M | $0.00 | -$0.39 | 8 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.35 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.58 | 0 |